• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

道德地利用新冠病毒宿主基因组数据。

Ethically utilising COVID-19 host-genomic data.

作者信息

Gyngell Christopher, Christodoulou John, Savulescu Julian

机构信息

Murdoch Children's Research Institute, Melbourne, Australia.

Department of Paediatrics, University of Melbourne, Melbourne, Australia.

出版信息

NPJ Genom Med. 2021 May 10;6(1):31. doi: 10.1038/s41525-021-00194-9.

DOI:10.1038/s41525-021-00194-9
PMID:33972547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8110518/
Abstract

Genetic variants that influence susceptibility to COVID-19 have recently been identified. In this manuscript, we identify and discuss some of the ethical and practical issues raised by these studies. We first outline the ethical case for providing COVID-19 susceptibility testing to healthcare workers, as well as highlighting risks associated with privacy and discrimination. We then argue that the existence of genetically susceptible individuals has implications for the ethical conduct of COVID-19 human challenge trials. Finally, we discuss the ethical issues that could arise from other COVID-19 host–genome interactions, including the prospect of personalized vaccines.

摘要

最近已确定了影响对新冠病毒易感性的基因变异。在本论文中,我们识别并讨论了这些研究引发的一些伦理和实际问题。我们首先概述了为医护人员提供新冠病毒易感性检测的伦理依据,同时强调了与隐私和歧视相关的风险。然后我们认为,基因易感个体的存在对新冠病毒人体挑战试验的伦理行为具有影响。最后,我们讨论了其他新冠病毒宿主-基因组相互作用可能引发的伦理问题,包括个性化疫苗的前景。

相似文献

1
Ethically utilising COVID-19 host-genomic data.道德地利用新冠病毒宿主基因组数据。
NPJ Genom Med. 2021 May 10;6(1):31. doi: 10.1038/s41525-021-00194-9.
2
The ethics of using COVID-19 host genomic information for clinical and public health decision-making: A survey of US health professionals.利用 COVID-19 宿主基因组信息进行临床和公共卫生决策的伦理问题:对美国卫生专业人员的调查。
HGG Adv. 2024 Jan 11;5(1):100255. doi: 10.1016/j.xhgg.2023.100255. Epub 2023 Nov 17.
3
Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?基因护照的伦理问题:基因抗性者是否应免于封锁和隔离?
J Med Ethics. 2021 Jun 25;48(10):689-94. doi: 10.1136/medethics-2021-107297.
4
Clinical Research without Consent: Challenges for COVID-19 Research.
J Law Med. 2020 Dec;28(1):90-106.
5
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.SARS-CoV-2 表现出宿主内基因组可塑性和低频多态准种。
J Clin Virol. 2020 Oct;131:104585. doi: 10.1016/j.jcv.2020.104585. Epub 2020 Aug 11.
6
Ethically problematic treatment decisions in different medical specialties.不同医学专科中存在伦理问题的治疗决策。
J Med Ethics. 2008 Apr;34(4):262-7. doi: 10.1136/jme.2007.020529.
7
Associations between job satisfaction, person-centredness, and ethically difficult situations in nursing homes-A cross-sectional study.养老院护士工作满意度、以患者为中心程度与伦理困境的相关性:一项横断面研究。
J Adv Nurs. 2019 May;75(5):979-988. doi: 10.1111/jan.13890. Epub 2018 Nov 20.
8
A Critical Assessment of COVID-19 Genomic Vaccines.对 COVID-19 基因组疫苗的批判性评估。
Curr Top Med Chem. 2023;23(27):2552-2589. doi: 10.2174/1568026623666230825094341.
9
Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study.基于基因组分析确定的耐药突变对免疫功能低下的持续性 SARS-CoV-2 感染者进行治疗的临床经验:一项描述性研究。
BMC Infect Dis. 2023 Nov 9;23(1):780. doi: 10.1186/s12879-023-08797-6.
10
Participants' informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable.住院COVID-19患者适应性平台药物试验中参与者的知情同意:并非所有方法在伦理上都可接受。
Eur J Intern Med. 2022 Sep;103:1-3. doi: 10.1016/j.ejim.2022.06.018. Epub 2022 Jun 28.

引用本文的文献

1
Exploring the ethics of genetic prioritisation for COVID-19 vaccines.探讨新冠病毒疫苗基因优先排序的伦理问题。
Eur J Hum Genet. 2022 Aug;30(8):875-879. doi: 10.1038/s41431-022-01058-1. Epub 2022 Mar 7.

本文引用的文献

1
Statistical power in COVID-19 case-control host genomic study design.在 COVID-19 病例对照宿主基因组研究设计中的统计功效。
Genome Med. 2020 Dec 28;12(1):115. doi: 10.1186/s13073-020-00818-2.
2
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.COVID-19 人体挑战研究的伦理可接受性的关键标准:世卫组织工作组的报告。
Vaccine. 2021 Jan 22;39(4):633-640. doi: 10.1016/j.vaccine.2020.10.075. Epub 2020 Oct 28.
3
Genetic mechanisms of critical illness in COVID-19.新型冠状病毒肺炎危重症的遗传机制。
Nature. 2021 Mar;591(7848):92-98. doi: 10.1038/s41586-020-03065-y. Epub 2020 Dec 11.
4
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review.全球 COVID-19 医护人员的感染和死亡率:系统综述。
BMJ Glob Health. 2020 Dec;5(12). doi: 10.1136/bmjgh-2020-003097.
5
Genomics in the era of COVID-19: ethical implications for clinical practice and public health.新冠疫情时代的基因组学:对临床实践和公共卫生的伦理影响。
Genome Med. 2020 Nov 9;12(1):95. doi: 10.1186/s13073-020-00792-9.
6
Good reasons to vaccinate: mandatory or payment for risk?有充分理由接种疫苗:强制接种还是为风险付费?
J Med Ethics. 2021 Feb;47(2):78-85. doi: 10.1136/medethics-2020-106821. Epub 2020 Nov 5.
7
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.与 SARS-CoV-2 感染易感性和 COVID-19 疾病严重程度相关的人类遗传因素。
Hum Genomics. 2020 Oct 22;14(1):40. doi: 10.1186/s40246-020-00290-4.
8
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.严重 COVID-19 的主要遗传风险因素来自尼安德特人。
Nature. 2020 Nov;587(7835):610-612. doi: 10.1038/s41586-020-2818-3. Epub 2020 Sep 30.
9
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
10
Developing COVID-19 vaccines.研发新冠疫苗。
Nat Med. 2020 Sep 10. doi: 10.1038/d41591-020-00029-7.